U.S. flag

An official website of the United States government

NM_000018.4(ACADVL):c.1611_1627dup (p.Phe543fs) AND Very long chain acyl-CoA dehydrogenase deficiency

Germline classification:
Likely pathogenic (2 submissions)
Last evaluated:
Sep 20, 2022
Review status:
3 stars out of maximum of 4 stars
reviewed by expert panel
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001050363.7

Allele description [Variation Report for NM_000018.4(ACADVL):c.1611_1627dup (p.Phe543fs)]

NM_000018.4(ACADVL):c.1611_1627dup (p.Phe543fs)

Gene:
ACADVL:acyl-CoA dehydrogenase very long chain [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000018.4(ACADVL):c.1611_1627dup (p.Phe543fs)
Other names:
NM_000018.4(ACADVL):c.1611_1627dup; p.Phe543fs
HGVS:
  • NC_000017.11:g.7224485_7224501dup
  • NG_007975.1:g.9652_9668dup
  • NG_008391.2:g.555_571dup
  • NG_033038.1:g.15049_15065dup
  • NM_000018.4:c.1611_1627dupMANE SELECT
  • NM_001033859.3:c.1545_1561dup
  • NM_001270447.2:c.1680_1696dup
  • NM_001270448.2:c.1383_1399dup
  • NP_000009.1:p.Phe543fs
  • NP_001029031.1:p.Phe521fs
  • NP_001257376.1:p.Phe566fs
  • NP_001257377.1:p.Phe467fs
  • NC_000017.10:g.7127798_7127799insGCAGTACGGGCTCTGGA
  • NC_000017.10:g.7127804_7127820dup
  • NM_000018.3:c.1611_1627dup
Protein change:
F467fs
Links:
Molecular consequence:
  • NM_000018.4:c.1611_1627dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001033859.3:c.1545_1561dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001270447.2:c.1680_1696dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_001270448.2:c.1383_1399dup - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Very long chain acyl-CoA dehydrogenase deficiency (ACADVLD)
Synonyms:
VLCAD deficiency
Identifiers:
MONDO: MONDO:0008723; MedGen: C3887523; Orphanet: 26793; OMIM: 201475

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001214465Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Mar 31, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

SCV002576769ClinGen ACADVL Variant Curation Expert Panel, ClinGen
reviewed by expert panel

(clingen acadvl acmg specifications v1)
Likely pathogenic
(Sep 20, 2022)
germlinecuration

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing, curation

Citations

PubMed

Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Andresen BS, Olpin S, Poorthuis BJ, Scholte HR, Vianey-Saban C, Wanders R, Ijlst L, Morris A, Pourfarzam M, Bartlett K, Baumgartner ER, deKlerk JB, Schroeder LD, Corydon TJ, Lund H, Winter V, Bross P, Bolund L, Gregersen N.

Am J Hum Genet. 1999 Feb;64(2):479-94.

PubMed [citation]
PMID:
9973285
PMCID:
PMC1377757

Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA.

Hum Mol Genet. 2001 Sep 15;10(19):2069-77.

PubMed [citation]
PMID:
11590124
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV001214465.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change creates a premature translational stop signal (p.Phe543Tyrfs*15) in the ACADVL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADVL are known to be pathogenic (PMID: 9973285, 11590124). For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 846935). This variant has not been reported in the literature in individuals affected with ACADVL-related conditions. This variant is not present in population databases (gnomAD no frequency).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From ClinGen ACADVL Variant Curation Expert Panel, ClinGen, SCV002576769.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcurationnot provided

Description

The c.1611_1627dup (p.Phe543Tyrfs*15) variant in ACADVL is a frameshift predicted to cause a premature stop codon in biologically relevant exon 17/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1: PMIDs 9973285, 11590124). This variant is absent from gnomAD v2.1.1 (PM2_Supporting). To our knowledge, this variant has not been reported in the literature in any individuals with VLCADD. The ACADVL Variant Curation Expert Panel VCEP classified the variant as likely pathogenic based on PVS1+PM2_supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024